Kane Biotech Announces Additional coactiv+™ Animal Health Licensing Agreement
April 18, 2023 07:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, April 18, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces that it has signed a licensing agreement with...
Kane Biotech to Present at Symposium on Advanced Wound Care Fall Forum
October 13, 2022 16:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that the Company will be presenting at the Symposium...
Kane Biotech to Release Second Quarter 2022 Financial Results on August 25, 2022 – Conference Call to Follow
August 18, 2022 16:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech Announces First Quarter 2022 Financial Results
May 26, 2022 16:05 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, May 26, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech Obtains ISO 13485 Certification
May 18, 2022 08:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, May 18, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), announced today that it has obtained ISO 13485:2016 certification...
Kane Biotech Announces Update on Private Placement
May 06, 2022 08:30 ET
|
Kane Biotech Inc.
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 06, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane...
Kane Biotech Announces Extension of Private Placement Offering
April 29, 2022 16:05 ET
|
Kane Biotech Inc.
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, April 29, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane...
Kane Biotech to Release Second Quarter 2021 Financial Results on August 26 – Conference Call to Follow
August 19, 2021 16:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech Expands its Wound Care and Surgical Portfolio with a coactiv+TM Antimicrobial Hydrogel
July 22, 2021 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, July 22, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. announces plans to expand its wound care and surgical portfolio with an antimicrobial hydrogel based on its best-in-class...
Kane Biotech Announces Adoption of Performance and Restricted Share Unit Plan and Amended and Restated Stock Option Plan
June 09, 2021 16:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, June 09, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announced that, at the annual and special meeting of...